| | Heart research focusing on obesity, atrial fib, diabetes - Drug Topics (Site not responding. Last check: 2007-10-09) |
 | | Significant favorable lipid changes independent of weight loss and effects on insulin resistance were also found for RMN 20 mg. |
 | | Discontinuations for serious adverse events were similar between groups: 8.3% for RMN 5 mg, 14.5% for RMN 20 mg, and 9.2% for placebo. |
 | | Van Gaal concluded that treatment with RMN brought about significant reductions in weight, waist circumference/abdominal obesity, and lipid and glycemic profile with a good safety profile. |
| www.drugtopics.com /drugtopics/article/articleDetail.jsp?id=129034 (621 words) |